Heart transplant recipient survivor from COVID-19: The first case of Turkey.
Identifieur interne : 001261 ( Main/Exploration ); précédent : 001260; suivant : 001262Heart transplant recipient survivor from COVID-19: The first case of Turkey.
Auteurs : Güle Ç Nar [Turquie] ; Cahit Sar Cao Lu [Turquie] ; Bahad R Nan [Turquie] ; Rem Dinçer [Turquie] ; Mehmet Çak C [Turquie] ; Tamer Say N [Turquie] ; Alpay Azap [Turquie] ; Ahmet Rüçhan Akar [Turquie]Source :
- Turk gogus kalp damar cerrahisi dergisi [ 1301-5680 ] ; 2020.
Abstract
Any highly infectious and rapidly spreading disease is a primary concern for immunocompromised solid organ transplant recipients. The number of data about the spectrum of clinical illness, the treatment modalities, and the outcomes of COVID-19 in this vulnerable population is scant and still remains empirical. Herein, we report the first COVID-19 case of a heart transplant recipient in Turkey who presented with fever, postnasal discharge, and myalgias for two days. The possibility of lung involvement was ruled out by thoracic computed tomography. Despite stable vital signs, we reduced the intensity of immunosuppressive therapy and maintained home self-isolation promptly. We also commenced a five-day course of hydroxychloroquine 200 mg q12h initially. After confirmation of real-time reverse-transcriptase-polymerasechain- reaction testing of the nasopharyngeal swab positive for COVID-19, the patient was hospitalized. After a loading dose of favipiravir 1,600 mg b.i.d., the patient received a five-day course of favipiravir 600 mg q12h. He was discharged with cure after 23 days of hospital isolation and treatment. In conclusion, treatment process can be affected by the daily electrocardiography, hand-held portable echocardiography, myocardial injury markers, and pulse oximeter for selfmonitoring in the follow-up of previous heart transplant recipients suffering from COVID-19. The lack of treatment protocols in the solid organ transplant recipients with COVID-19 infection and the controversies about the protective effect of immunosuppression invite a global and update discussion.
DOI: 10.5606/tgkdc.dergisi.2020.20291
PubMed: 33403142
PubMed Central: PMC7759049
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Heart transplant recipient survivor from COVID-19: The first case of Turkey.</title><author><name sortKey="C Nar, Gule" sort="C Nar, Gule" uniqKey="C Nar G" first="Güle" last="Ç Nar">Güle Ç Nar</name><affiliation wicri:level="1"><nlm:affiliation>Department of Infectious Diseases and clinical Microbiology, Ankara University School of Medicine, Ankara, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Infectious Diseases and clinical Microbiology, Ankara University School of Medicine, Ankara</wicri:regionArea><wicri:noRegion>Ankara</wicri:noRegion></affiliation></author><author><name sortKey="Sar Cao Lu, Cahit" sort="Sar Cao Lu, Cahit" uniqKey="Sar Cao Lu C" first="Cahit" last="Sar Cao Lu">Cahit Sar Cao Lu</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiovascular Surgery, Ankara University School of Medicine, Ankara, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Cardiovascular Surgery, Ankara University School of Medicine, Ankara</wicri:regionArea><wicri:noRegion>Ankara</wicri:noRegion></affiliation></author><author><name sortKey=" Nan, Bahad R" sort=" Nan, Bahad R" uniqKey=" Nan B" first="Bahad R" last=" Nan">Bahad R Nan</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiovascular Surgery, Ankara University School of Medicine, Ankara, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Cardiovascular Surgery, Ankara University School of Medicine, Ankara</wicri:regionArea><wicri:noRegion>Ankara</wicri:noRegion></affiliation></author><author><name sortKey="Dincer, Rem" sort="Dincer, Rem" uniqKey="Dincer " first=" Rem" last="Dinçer"> Rem Dinçer</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Ankara University School of Medicine, Ankara, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Cardiology, Ankara University School of Medicine, Ankara</wicri:regionArea><wicri:noRegion>Ankara</wicri:noRegion></affiliation></author><author><name sortKey="Cak C, Mehmet" sort="Cak C, Mehmet" uniqKey="Cak C M" first="Mehmet" last="Çak C">Mehmet Çak C</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiovascular Surgery, Ankara University School of Medicine, Ankara, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Cardiovascular Surgery, Ankara University School of Medicine, Ankara</wicri:regionArea><wicri:noRegion>Ankara</wicri:noRegion></affiliation></author><author><name sortKey="Say N, Tamer" sort="Say N, Tamer" uniqKey="Say N T" first="Tamer" last="Say N">Tamer Say N</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Ankara University School of Medicine, Ankara, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Cardiology, Ankara University School of Medicine, Ankara</wicri:regionArea><wicri:noRegion>Ankara</wicri:noRegion></affiliation></author><author><name sortKey="Azap, Alpay" sort="Azap, Alpay" uniqKey="Azap A" first="Alpay" last="Azap">Alpay Azap</name><affiliation wicri:level="1"><nlm:affiliation>Department of Infectious Diseases and clinical Microbiology, Ankara University School of Medicine, Ankara, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Infectious Diseases and clinical Microbiology, Ankara University School of Medicine, Ankara</wicri:regionArea><wicri:noRegion>Ankara</wicri:noRegion></affiliation></author><author><name sortKey="Akar, Ahmet Ruchan" sort="Akar, Ahmet Ruchan" uniqKey="Akar A" first="Ahmet Rüçhan" last="Akar">Ahmet Rüçhan Akar</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiovascular Surgery, Ankara University School of Medicine, Ankara, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Cardiovascular Surgery, Ankara University School of Medicine, Ankara</wicri:regionArea><wicri:noRegion>Ankara</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:33403142</idno><idno type="pmid">33403142</idno><idno type="doi">10.5606/tgkdc.dergisi.2020.20291</idno><idno type="pmc">PMC7759049</idno><idno type="wicri:Area/Main/Corpus">000552</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000552</idno><idno type="wicri:Area/Main/Curation">000552</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000552</idno><idno type="wicri:Area/Main/Exploration">000552</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Heart transplant recipient survivor from COVID-19: The first case of Turkey.</title><author><name sortKey="C Nar, Gule" sort="C Nar, Gule" uniqKey="C Nar G" first="Güle" last="Ç Nar">Güle Ç Nar</name><affiliation wicri:level="1"><nlm:affiliation>Department of Infectious Diseases and clinical Microbiology, Ankara University School of Medicine, Ankara, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Infectious Diseases and clinical Microbiology, Ankara University School of Medicine, Ankara</wicri:regionArea><wicri:noRegion>Ankara</wicri:noRegion></affiliation></author><author><name sortKey="Sar Cao Lu, Cahit" sort="Sar Cao Lu, Cahit" uniqKey="Sar Cao Lu C" first="Cahit" last="Sar Cao Lu">Cahit Sar Cao Lu</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiovascular Surgery, Ankara University School of Medicine, Ankara, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Cardiovascular Surgery, Ankara University School of Medicine, Ankara</wicri:regionArea><wicri:noRegion>Ankara</wicri:noRegion></affiliation></author><author><name sortKey=" Nan, Bahad R" sort=" Nan, Bahad R" uniqKey=" Nan B" first="Bahad R" last=" Nan">Bahad R Nan</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiovascular Surgery, Ankara University School of Medicine, Ankara, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Cardiovascular Surgery, Ankara University School of Medicine, Ankara</wicri:regionArea><wicri:noRegion>Ankara</wicri:noRegion></affiliation></author><author><name sortKey="Dincer, Rem" sort="Dincer, Rem" uniqKey="Dincer " first=" Rem" last="Dinçer"> Rem Dinçer</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Ankara University School of Medicine, Ankara, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Cardiology, Ankara University School of Medicine, Ankara</wicri:regionArea><wicri:noRegion>Ankara</wicri:noRegion></affiliation></author><author><name sortKey="Cak C, Mehmet" sort="Cak C, Mehmet" uniqKey="Cak C M" first="Mehmet" last="Çak C">Mehmet Çak C</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiovascular Surgery, Ankara University School of Medicine, Ankara, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Cardiovascular Surgery, Ankara University School of Medicine, Ankara</wicri:regionArea><wicri:noRegion>Ankara</wicri:noRegion></affiliation></author><author><name sortKey="Say N, Tamer" sort="Say N, Tamer" uniqKey="Say N T" first="Tamer" last="Say N">Tamer Say N</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Ankara University School of Medicine, Ankara, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Cardiology, Ankara University School of Medicine, Ankara</wicri:regionArea><wicri:noRegion>Ankara</wicri:noRegion></affiliation></author><author><name sortKey="Azap, Alpay" sort="Azap, Alpay" uniqKey="Azap A" first="Alpay" last="Azap">Alpay Azap</name><affiliation wicri:level="1"><nlm:affiliation>Department of Infectious Diseases and clinical Microbiology, Ankara University School of Medicine, Ankara, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Infectious Diseases and clinical Microbiology, Ankara University School of Medicine, Ankara</wicri:regionArea><wicri:noRegion>Ankara</wicri:noRegion></affiliation></author><author><name sortKey="Akar, Ahmet Ruchan" sort="Akar, Ahmet Ruchan" uniqKey="Akar A" first="Ahmet Rüçhan" last="Akar">Ahmet Rüçhan Akar</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiovascular Surgery, Ankara University School of Medicine, Ankara, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Cardiovascular Surgery, Ankara University School of Medicine, Ankara</wicri:regionArea><wicri:noRegion>Ankara</wicri:noRegion></affiliation></author></analytic><series><title level="j">Turk gogus kalp damar cerrahisi dergisi</title><idno type="ISSN">1301-5680</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Any highly infectious and rapidly spreading disease is a primary concern for immunocompromised solid organ transplant recipients. The number of data about the spectrum of clinical illness, the treatment modalities, and the outcomes of COVID-19 in this vulnerable population is scant and still remains empirical. Herein, we report the first COVID-19 case of a heart transplant recipient in Turkey who presented with fever, postnasal discharge, and myalgias for two days. The possibility of lung involvement was ruled out by thoracic computed tomography. Despite stable vital signs, we reduced the intensity of immunosuppressive therapy and maintained home self-isolation promptly. We also commenced a five-day course of hydroxychloroquine 200 mg q12h initially. After confirmation of real-time reverse-transcriptase-polymerasechain- reaction testing of the nasopharyngeal swab positive for COVID-19, the patient was hospitalized. After a loading dose of favipiravir 1,600 mg b.i.d., the patient received a five-day course of favipiravir 600 mg q12h. He was discharged with cure after 23 days of hospital isolation and treatment. In conclusion, treatment process can be affected by the daily electrocardiography, hand-held portable echocardiography, myocardial injury markers, and pulse oximeter for selfmonitoring in the follow-up of previous heart transplant recipients suffering from COVID-19. The lack of treatment protocols in the solid organ transplant recipients with COVID-19 infection and the controversies about the protective effect of immunosuppression invite a global and update discussion.</div></front></TEI><pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33403142</PMID><DateRevised><Year>2021</Year><Month>01</Month><Day>11</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1301-5680</ISSN><JournalIssue CitedMedium="Print"><Volume>28</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Turk gogus kalp damar cerrahisi dergisi</Title><ISOAbbreviation>Turk Gogus Kalp Damar Cerrahisi Derg</ISOAbbreviation></Journal><ArticleTitle>Heart transplant recipient survivor from COVID-19: The first case of Turkey.</ArticleTitle><Pagination><MedlinePgn>674-679</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5606/tgkdc.dergisi.2020.20291</ELocationID><Abstract><AbstractText>Any highly infectious and rapidly spreading disease is a primary concern for immunocompromised solid organ transplant recipients. The number of data about the spectrum of clinical illness, the treatment modalities, and the outcomes of COVID-19 in this vulnerable population is scant and still remains empirical. Herein, we report the first COVID-19 case of a heart transplant recipient in Turkey who presented with fever, postnasal discharge, and myalgias for two days. The possibility of lung involvement was ruled out by thoracic computed tomography. Despite stable vital signs, we reduced the intensity of immunosuppressive therapy and maintained home self-isolation promptly. We also commenced a five-day course of hydroxychloroquine 200 mg q12h initially. After confirmation of real-time reverse-transcriptase-polymerasechain- reaction testing of the nasopharyngeal swab positive for COVID-19, the patient was hospitalized. After a loading dose of favipiravir 1,600 mg b.i.d., the patient received a five-day course of favipiravir 600 mg q12h. He was discharged with cure after 23 days of hospital isolation and treatment. In conclusion, treatment process can be affected by the daily electrocardiography, hand-held portable echocardiography, myocardial injury markers, and pulse oximeter for selfmonitoring in the follow-up of previous heart transplant recipients suffering from COVID-19. The lack of treatment protocols in the solid organ transplant recipients with COVID-19 infection and the controversies about the protective effect of immunosuppression invite a global and update discussion.</AbstractText><CopyrightInformation>Copyright © 2020, Turkish Society of Cardiovascular Surgery.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Çınar</LastName><ForeName>Güle</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and clinical Microbiology, Ankara University School of Medicine, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarıcaoğlu</LastName><ForeName>Cahit</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Ankara University School of Medicine, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>İnan</LastName><ForeName>Bahadır</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Ankara University School of Medicine, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dinçer</LastName><ForeName>İrem</ForeName><Initials>İ</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Ankara University School of Medicine, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Çakıcı</LastName><ForeName>Mehmet</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Ankara University School of Medicine, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sayın</LastName><ForeName>Tamer</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Ankara University School of Medicine, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azap</LastName><ForeName>Alpay</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and clinical Microbiology, Ankara University School of Medicine, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akar</LastName><ForeName>Ahmet Rüçhan</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Ankara University School of Medicine, Ankara, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Turkey</Country><MedlineTA>Turk Gogus Kalp Damar Cerrahisi Derg</MedlineTA><NlmUniqueID>100887967</NlmUniqueID><ISSNLinking>1301-5680</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">heart transplantation</Keyword><Keyword MajorTopicYN="N">simmunocompromised</Keyword></KeywordList><CoiStatement>Conflict of Interest: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>06</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>08</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>6</Day><Hour>5</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33403142</ArticleId><ArticleId IdType="doi">10.5606/tgkdc.dergisi.2020.20291</ArticleId><ArticleId IdType="pmc">PMC7759049</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pharmacotherapy. 2020 Jun;40(6):517-524</Citation><ArticleIdList><ArticleId IdType="pubmed">32339304</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Cardiol. 2020 May 13;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32402056</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Cardiol. 2020 Jul 1;5(7):751-753</Citation><ArticleIdList><ArticleId IdType="pubmed">32219362</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Discov. 2020 Mar 18;6:16</Citation><ArticleIdList><ArticleId IdType="pubmed">32194981</ArticleId></ArticleIdList></Reference><Reference><Citation>J Heart Lung Transplant. 2020 May;39(5):496-497</Citation><ArticleIdList><ArticleId IdType="pubmed">32362394</ArticleId></ArticleIdList></Reference><Reference><Citation>J Heart Lung Transplant. 2020 May;39(5):408-409</Citation><ArticleIdList><ArticleId IdType="pubmed">32253113</ArticleId></ArticleIdList></Reference><Reference><Citation>J Heart Lung Transplant. 2020 May;39(5):405-407</Citation><ArticleIdList><ArticleId IdType="pubmed">32362390</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Transplant. 2020 Jul;20(7):1768-1772</Citation><ArticleIdList><ArticleId IdType="pubmed">32090448</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacol Ther. 2020 May;209:107512</Citation><ArticleIdList><ArticleId IdType="pubmed">32097670</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayo Clin Proc. 2020 Jun;95(6):1213-1221</Citation><ArticleIdList><ArticleId IdType="pubmed">32359771</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Res. 2020 Mar;30(3):269-271</Citation><ArticleIdList><ArticleId IdType="pubmed">32020029</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rhythm. 2020 Sep;17(9):1472-1479</Citation><ArticleIdList><ArticleId IdType="pubmed">32438018</ArticleId></ArticleIdList></Reference><Reference><Citation>Engineering (Beijing). 2020 Oct;6(10):1192-1198</Citation><ArticleIdList><ArticleId IdType="pubmed">32346491</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Cardiol. 2020 Jul 1;5(7):802-810</Citation><ArticleIdList><ArticleId IdType="pubmed">32211816</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Transplant. 2020 Jul;20(7):1911-1915</Citation><ArticleIdList><ArticleId IdType="pubmed">32315122</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2020 Jun 23;141(25):2048-2051</Citation><ArticleIdList><ArticleId IdType="pubmed">32314596</ArticleId></ArticleIdList></Reference><Reference><Citation>J Heart Lung Transplant. 2020 Jul;39(7):732-733</Citation><ArticleIdList><ArticleId IdType="pubmed">32430156</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Pharm Res. 2020 Aug;43(8):765-772</Citation><ArticleIdList><ArticleId IdType="pubmed">32740801</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Turquie</li></country></list><tree><country name="Turquie"><noRegion><name sortKey="C Nar, Gule" sort="C Nar, Gule" uniqKey="C Nar G" first="Güle" last="Ç Nar">Güle Ç Nar</name></noRegion><name sortKey=" Nan, Bahad R" sort=" Nan, Bahad R" uniqKey=" Nan B" first="Bahad R" last=" Nan">Bahad R Nan</name><name sortKey="Akar, Ahmet Ruchan" sort="Akar, Ahmet Ruchan" uniqKey="Akar A" first="Ahmet Rüçhan" last="Akar">Ahmet Rüçhan Akar</name><name sortKey="Azap, Alpay" sort="Azap, Alpay" uniqKey="Azap A" first="Alpay" last="Azap">Alpay Azap</name><name sortKey="Cak C, Mehmet" sort="Cak C, Mehmet" uniqKey="Cak C M" first="Mehmet" last="Çak C">Mehmet Çak C</name><name sortKey="Dincer, Rem" sort="Dincer, Rem" uniqKey="Dincer " first=" Rem" last="Dinçer"> Rem Dinçer</name><name sortKey="Sar Cao Lu, Cahit" sort="Sar Cao Lu, Cahit" uniqKey="Sar Cao Lu C" first="Cahit" last="Sar Cao Lu">Cahit Sar Cao Lu</name><name sortKey="Say N, Tamer" sort="Say N, Tamer" uniqKey="Say N T" first="Tamer" last="Say N">Tamer Say N</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001261 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001261 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:33403142
|texte= Heart transplant recipient survivor from COVID-19: The first case of Turkey.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:33403142" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidChloroV1
| This area was generated with Dilib version V0.6.38. |  |